• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchSynairgen
    Picture of Synairgen logo

    SNG — Synairgen Share News

    0.95p0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      £10.48m
    • Enterprise Value
      £1.88m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SNG Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SNG Dividends
    • Interim Results

      21/09/2023 07:00
    • Annual General Meeting Presentation

      29/06/2023 10:00
    • Brief: Synairgen Says FY Basic Loss Per Share 8.76p

      27/04/2023 08:25
    • 2022 Full Year Results

      27/04/2023 07:00
    • Notice of Full Year results

      17/04/2023 07:00
    • Second Price Monitoring Extn

      03/02/2023 16:40
    • Price Monitoring Extension

      03/02/2023 16:35
    • Price Monitoring Extension

      17/01/2023 16:35
    • Second Price Monitoring Extn

      13/01/2023 16:40
    • Price Monitoring Extension

      13/01/2023 16:35
    • SPRINTER Trial Results Published

      23/12/2022 11:30
    • Price Monitoring Extension

      14/12/2022 16:35
    • Board Changes

      01/12/2022 07:00
    • Second Price Monitoring Extn

      07/11/2022 16:40
    • Price Monitoring Extension

      07/11/2022 16:35
    • Second Price Monitoring Extn

      03/11/2022 16:40
    • Price Monitoring Extension

      03/11/2022 16:35
    • Price Monitoring Extension

      20/10/2022 16:35
    • Holding(s) in Company

      06/10/2022 13:35
    • Brief: Synairgen Announces Positive Data From US NIH-LED ACTIV-2 Phase 2 Trial

      04/10/2022 07:38
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.